.Bicara Therapies and Zenas Biopharma have provided fresh incentive to the IPO market with filings t...
.Genentech will close its cancer immunology research department, as well as unit mind and well-known...
.Kezar Life Sciences is losing its unpromising phase 1 solid tumor drug as the biotech goes all-in o...
.Despite izokibep maintaining its own newly found winning touch in the facility, Acelyrin is no long...
.Rivus Pharmaceuticals has actually plumped up the potential customers of its fat-busting, muscle-sp...
.Ovid Therapeutics currently uncovered final month that it was trimming its head count as the busine...
.Eli Lilly has opened a $700 thousand R&D center in the Boston ma Seaport, improving its RNA and ...
.Just 5 months after protecting a $one hundred million IPO, Vast Bio is actually currently laying of...
.The first stages of oncology R&D aren't except intriguing brand new methods, as well as Halda Re...
.Psychopharmacology has actually drawn three short articles about midstage clinical test data analyz...